This World Congress Summit convenes leaders in pharmaceutical, biotech and medical device compliance to discuss compliant HCP Interaction Management in your workforce from both a strategic and operational level.
With the increasing interest paid by federal agencies to potential statute violations as well as existing uncertainty with current guidelines such as social media and health economics data, few can afford to overlook potential areas of risk or weakness in their programs and methods. This includes a responsibility for all interactions between an employee workforce in pharmaceuticals and health care providers, ranging from sales, to marketing, and medical liaison divisions and 3rd party interaction on social media platforms.
This Summit provides a crucial opportunity to network with your peers and to hear national perspectives on:
- Regulatory Guidelines and Guidance
- Current Enforcement Trends for Federal Agencies
- 3rd Party Responsibilities for Pharmaceutical Presence in Social Media
Just Added:
|
||
|
||
Federal Perspective
|
||
- Monitoring and Auditing your Internal and Remote Sales Team
- Marketing Teams, Materials and Publishing Programs
- The Challenges of Promotional Review
- Medical Liaison Communications and Physician Requests for Information
- Creating a Culture of Compliance throughout your Organization
- Building a Global Compliance Infrastructure from the Ground Up
- Appropriate Health Economics Outcomes & Data Communication and Education
- Utilizing Mobile Apps and Technology to Promote Compliance, Train and Educate your Workforce
